![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C07D 277/54 | (2006.01) |
C07D 417/12 | (2013.01) | ||
C07D 417/12 | (2006.01) | ||
C07D 417/14 | (2013.01) | ||
C07D 487/10 | (2006.01) | ||
C07D 487/04 | (2013.01) | ||
A61K 31/426 | (2006.01) | ||
C07D 487/08 | (2013.01) | ||
A61K 31/427 | (2006.01) | ||
C07D 487/10 | (2013.01) | ||
A61K 31/428 | (2006.01) | ||
C07D 495/04 | (2013.01) | ||
A61P 35/00 | (2006.01) | ||
C07D 277/54 | (2013.01) | ||
A61P 35/00 | (2018.01) | ||
A61P 43/00 | (2018.01) |
(11) | Number of the document | 3534899 |
(13) | Kind of document | T |
(96) | European patent application number | 17868729.9 |
Date of filing the European patent application | 2017-11-03 | |
(97) | Date of publication of the European application | 2019-09-11 |
(45) | Date of publication and mention of the grant of the patent | 2022-06-01 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2017/059871 |
Date | 2017-11-03 |
(87) | Number | WO 2018/089261 |
Date | 2018-05-17 |
(30) | Number | Date | Country code |
201662417083 P | 2016-11-03 | US |
(72) |
HUDSON, Ryan , US
BEAUSOLEIL, Anne-Marie , US
|
(73) |
Corvus Pharmaceuticals, Inc. ,
863 Mitten Road
Suite 102, Burlingame, CA 94010,
US
|
(54) | COMPOUNDS AND METHODS FOR MODULATING INTERLEUKIN-2-INDUCIBLE T-CELL KINASE |
COMPOUNDS AND METHODS FOR MODULATING INTERLEUKIN-2-INDUCIBLE T-CELL KINASE |